Listen to the Scientists!
academic videos, and topics

Your search is running...

Americans spend more than $200 billion a year on prescription drugs. What are they getting for their money? Dr. Marcia Angell, senior lecturer of Harvard Medical School's Department of Social Medicine and former editor-in-chief of the New England Journal of Medicine, answers that question and more in this installment of the President's Lecture Series at The University of Montana. This presentation, 'The Truth About the Drug Companies,'
Pharmaceutical Industry Challenges Presented by: Gaëlle Fleitour Featuring: • Philippe Duneton (UNITAID) • Ellen F.M't Hoen (Medicines Law & Policy) • Bertrand Parmentier (Pierre Fabre Laboratories) • Tomas Philipson (University of Chicago) • Prashant Yadav (University of Michigan)

Continuum Solutions partner Carol Perlman talks about an ethical shift that she witnessed at her pharmaceutical company.

An Ex pharma Rep speaks out about Pharma and their real motivations and lack there of to cure , heal and care for you or your best interests. Only to cure the space in their pockets not yet filled with your cash.
In this lecture from Brown University, Marcia Angell talk about Ethics in the Pharmaceutical Industry.
The cure for cancer has been delayed because pharmaceutical companies will only make drugs that they are sure will turn a profit, according to Professor Paul Workman, chief executive of the Institute of Cancer Research in London. We look at changes in the treatment of cancer, the significance of private companies and how larger companies can be given incentives to invest in cancer research
Ten pharmaceutical companies from the U.S. and Europe have formed a nonprofit to accelerate the development of new drugs. The organization, TransCelerate BioPharma, will be headquartered in Philadelphia. The founding companies are Abbott Laboratories, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, Roche Holding AG's Genentech, and Sanofi SA. InBalance Health, a company that provides doctor-formulated, alternative food bar and supplement solutions for prediabetes and Type 2 diabetes patients, has announced its launch and new healthy snack products. The company's INbars are allergen-free and offer whole food nutrients, and are also useful for people with weight-loss or glucose management goals. Novo Nordisk has been ranked in the top 10 of healthcare companies in the Carbon Disclosure Project's Global 500 2012 report. Compared to 2011, Novo Nordisk improved its score by 1 to 90 out of 100. According to the CDP, the score shows that the company has recognized climate change as a priority for strategy. For more information on these and other stories, go to